- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x F9F: 2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE(Non-covalent)
- 40 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.2: 6 residues within 4Å:- Chain A: L.191, P.192, L.193, Q.210, A.222, A.226
Ligand excluded by PLIPDMS.3: 5 residues within 4Å:- Chain A: N.12, E.16, V.224, A.228, A.268
Ligand excluded by PLIPDMS.4: 4 residues within 4Å:- Chain A: S.55, L.69, F.72
- Chain B: G.162
Ligand excluded by PLIPDMS.5: 9 residues within 4Å:- Chain A: Y.115, V.128, V.131, S.136, F.139, R.140, P.150, I.151, F.152
Ligand excluded by PLIPDMS.6: 4 residues within 4Å:- Chain A: P.217, F.258, A.261, M.262
Ligand excluded by PLIPDMS.7: 5 residues within 4Å:- Chain A: I.41, H.92, P.93, T.94, I.95
Ligand excluded by PLIPDMS.8: 3 residues within 4Å:- Chain A: A.43, R.256, S.260
Ligand excluded by PLIPDMS.9: 3 residues within 4Å:- Chain A: Q.165, S.168, Y.169
Ligand excluded by PLIPDMS.14: 4 residues within 4Å:- Chain B: Y.133, E.172, R.175, D.176
Ligand excluded by PLIPDMS.15: 2 residues within 4Å:- Chain B: R.363, E.364
Ligand excluded by PLIPDMS.16: 5 residues within 4Å:- Chain B: I.262, G.265, H.267, H.273
- Ligands: DMS.20
Ligand excluded by PLIPDMS.17: 3 residues within 4Å:- Chain B: Q.36, Q.42
- Ligands: CL.32
Ligand excluded by PLIPDMS.18: 9 residues within 4Å:- Chain B: P.56, T.57, A.58, Q.215
- Chain D: K.50, G.54, R.55, P.56
- Ligands: DMS.54
Ligand excluded by PLIPDMS.19: 2 residues within 4Å:- Chain B: K.99, R.100
Ligand excluded by PLIPDMS.20: 8 residues within 4Å:- Chain B: H.267, H.273, G.274, R.275, M.286, M.287, Q.288
- Ligands: DMS.16
Ligand excluded by PLIPDMS.21: 5 residues within 4Å:- Chain B: Q.42, F.45, A.46, L.49, M.207
Ligand excluded by PLIPDMS.23: 5 residues within 4Å:- Chain B: F.385, H.388
- Chain D: S.143, F.147
- Ligands: DMS.62
Ligand excluded by PLIPDMS.24: 9 residues within 4Å:- Chain B: R.141, E.296, S.297, Y.298, S.299, S.301, A.302, L.304, D.305
Ligand excluded by PLIPDMS.25: 2 residues within 4Å:- Chain B: E.211, Q.215
Ligand excluded by PLIPDMS.26: 6 residues within 4Å:- Chain B: S.143, V.146, F.147, R.150
- Chain D: H.388
- Ligands: DMS.59
Ligand excluded by PLIPDMS.38: 6 residues within 4Å:- Chain C: L.191, P.192, L.193, Q.210, A.222, A.226
Ligand excluded by PLIPDMS.39: 5 residues within 4Å:- Chain C: N.12, E.16, V.224, A.228, A.268
Ligand excluded by PLIPDMS.40: 4 residues within 4Å:- Chain C: S.55, L.69, F.72
- Chain D: G.162
Ligand excluded by PLIPDMS.41: 9 residues within 4Å:- Chain C: Y.115, V.128, V.131, S.136, F.139, R.140, P.150, I.151, F.152
Ligand excluded by PLIPDMS.42: 4 residues within 4Å:- Chain C: P.217, F.258, A.261, M.262
Ligand excluded by PLIPDMS.43: 5 residues within 4Å:- Chain C: I.41, H.92, P.93, T.94, I.95
Ligand excluded by PLIPDMS.44: 3 residues within 4Å:- Chain C: A.43, R.256, S.260
Ligand excluded by PLIPDMS.45: 3 residues within 4Å:- Chain C: Q.165, S.168, Y.169
Ligand excluded by PLIPDMS.50: 4 residues within 4Å:- Chain D: Y.133, E.172, R.175, D.176
Ligand excluded by PLIPDMS.51: 2 residues within 4Å:- Chain D: R.363, E.364
Ligand excluded by PLIPDMS.52: 5 residues within 4Å:- Chain D: I.262, G.265, H.267, H.273
- Ligands: DMS.56
Ligand excluded by PLIPDMS.53: 3 residues within 4Å:- Chain D: Q.36, Q.42
- Ligands: CL.68
Ligand excluded by PLIPDMS.54: 9 residues within 4Å:- Chain B: K.50, G.54, R.55, P.56
- Chain D: P.56, T.57, A.58, Q.215
- Ligands: DMS.18
Ligand excluded by PLIPDMS.55: 2 residues within 4Å:- Chain D: K.99, R.100
Ligand excluded by PLIPDMS.56: 8 residues within 4Å:- Chain D: H.267, H.273, G.274, R.275, M.286, M.287, Q.288
- Ligands: DMS.52
Ligand excluded by PLIPDMS.57: 5 residues within 4Å:- Chain D: Q.42, F.45, A.46, L.49, M.207
Ligand excluded by PLIPDMS.59: 5 residues within 4Å:- Chain B: S.143, F.147
- Chain D: F.385, H.388
- Ligands: DMS.26
Ligand excluded by PLIPDMS.60: 9 residues within 4Å:- Chain D: R.141, E.296, S.297, Y.298, S.299, S.301, A.302, L.304, D.305
Ligand excluded by PLIPDMS.61: 2 residues within 4Å:- Chain D: E.211, Q.215
Ligand excluded by PLIPDMS.62: 6 residues within 4Å:- Chain B: H.388
- Chain D: S.143, V.146, F.147, R.150
- Ligands: DMS.23
Ligand excluded by PLIP- 22 x CL: CHLORIDE ION(Non-functional Binders)
CL.10: 1 residues within 4Å:- Chain A: F.114
Ligand excluded by PLIPCL.11: 2 residues within 4Å:- Chain A: R.140, Y.169
Ligand excluded by PLIPCL.12: 3 residues within 4Å:- Chain A: A.167, G.170, H.204
Ligand excluded by PLIPCL.29: 1 residues within 4Å:- Chain B: G.274
Ligand excluded by PLIPCL.30: 1 residues within 4Å:- Chain B: R.150
Ligand excluded by PLIPCL.31: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.32: 3 residues within 4Å:- Chain B: Q.36, K.37
- Ligands: DMS.17
Ligand excluded by PLIPCL.33: 1 residues within 4Å:- Chain B: E.11
Ligand excluded by PLIPCL.34: 3 residues within 4Å:- Chain B: K.219, E.220, G.221
Ligand excluded by PLIPCL.35: 1 residues within 4Å:- Chain B: F.9
Ligand excluded by PLIPCL.36: 2 residues within 4Å:- Chain B: K.368, E.369
Ligand excluded by PLIPCL.46: 1 residues within 4Å:- Chain C: F.114
Ligand excluded by PLIPCL.47: 2 residues within 4Å:- Chain C: R.140, Y.169
Ligand excluded by PLIPCL.48: 3 residues within 4Å:- Chain C: A.167, G.170, H.204
Ligand excluded by PLIPCL.65: 1 residues within 4Å:- Chain D: G.274
Ligand excluded by PLIPCL.66: 1 residues within 4Å:- Chain D: R.150
Ligand excluded by PLIPCL.67: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.68: 3 residues within 4Å:- Chain D: Q.36, K.37
- Ligands: DMS.53
Ligand excluded by PLIPCL.69: 1 residues within 4Å:- Chain D: E.11
Ligand excluded by PLIPCL.70: 3 residues within 4Å:- Chain D: K.219, E.220, G.221
Ligand excluded by PLIPCL.71: 1 residues within 4Å:- Chain D: F.9
Ligand excluded by PLIPCL.72: 2 residues within 4Å:- Chain D: K.368, E.369
Ligand excluded by PLIP- 2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
PLP.13: 15 residues within 4Å:- Chain B: A.85, H.86, K.87, T.190, G.232, G.233, G.234, S.235, N.236, G.303, L.304, E.350, S.351, A.377, G.378
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:K.87, B:A.377
- Hydrogen bonds: B:H.86, B:T.190, B:G.232, B:G.233, B:G.234, B:S.235, B:N.236, B:N.236
- Water bridges: B:T.190, B:T.190, B:S.235, B:S.235, B:A.237
- Salt bridges: B:H.86, B:K.87
- pi-Stacking: B:H.86
PLP.49: 15 residues within 4Å:- Chain D: A.85, H.86, K.87, T.190, G.232, G.233, G.234, S.235, N.236, G.303, L.304, E.350, S.351, A.377, G.378
16 PLIP interactions:16 interactions with chain D- Hydrophobic interactions: D:K.87, D:A.377
- Hydrogen bonds: D:T.190, D:T.190, D:G.232, D:G.233, D:G.234, D:S.235, D:N.236, D:N.236
- Water bridges: D:S.235, D:S.235, D:A.237
- Salt bridges: D:H.86, D:K.87
- pi-Stacking: D:H.86
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.22: 5 residues within 4Å:- Chain B: I.65, T.338, H.342, M.362, R.363
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.363, B:R.363
EDO.58: 5 residues within 4Å:- Chain D: I.65, T.338, H.342, M.362, R.363
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:R.363, D:R.363
- 4 x CS: CESIUM ION(Non-covalent)
CS.27: 6 residues within 4Å:- Chain B: V.231, G.232, E.256, G.268, P.270, S.308
2 PLIP interactions:1 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:G.232, H2O.24
CS.28: 3 residues within 4Å:- Chain B: T.66, T.69, T.71
2 PLIP interactions:1 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:T.71, H2O.28
CS.63: 6 residues within 4Å:- Chain D: V.231, G.232, E.256, G.268, P.270, S.308
2 PLIP interactions:1 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:G.232, H2O.59
CS.64: 3 residues within 4Å:- Chain D: T.66, T.69, T.71
2 PLIP interactions:1 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:T.71, H2O.63
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hilario, E. et al., The internal aldimine crystal structure of Salmonella typhimurium Tryptophan Synthase mutant beta-S377A in complex with inhibitor 2-({[4-(trifluoromethoxy)phenyl]sulfonyl}amino)ethyl dihydrogen phosphate (F9F) at the alpha-site and Cesium ion at the metal coordination site. To be Published
- Release Date
- 2021-07-28
- Peptides
- Tryptophan synthase alpha chain: AC
Tryptophan synthase beta chain: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AB
BD
B
SMTL ID : 7jhw.1
The internal aldimine crystal structure of Salmonella typhimurium Tryptophan Synthase mutant beta-S377A in complex with inhibitor 2-({[4-(trifluoromethoxy)phenyl]sulfonyl}amino)ethyl dihydrogen phosphate (F9F) at the alpha-site and Cesium ion at the metal coordination site
Tryptophan synthase alpha chain
Toggle Identical (AC)Tryptophan synthase beta chain
Toggle Identical (BD)Related Entries With Identical Sequence
1a50.1 | 1a5s.1 | 1bks.1 | 1c29.1 | 1c8v.1 | 1c9d.1 | 1cw2.1 | 1cx9.1 | 1fuy.1 | 1k3u.1 | 1k7e.1 | 1k7f.1 | 1k7x.1 | 1k8y.1 | 1k8z.1 | 1kfj.1 | 1qoq.1 | 1tjp.1 | 1ttp.1 | 1ttq.1 | 1ubs.1 | 2cle.1 | 2clf.1 | 2clh.1 | 2cli.1 | 2cll.1 | 2clm.1 | 2clo.1 | 2j9x.1 | 2j9y.1 more...less...2rh9.1 | 2rhg.1 | 2trs.1 | 2tsy.1 | 2tys.1 | 2wsy.1 | 4hn4.1 | 4hpj.1 | 4hpx.1 | 4hpx.2 | 4ht3.1 | 4kkx.1 | 4wx2.1 | 4xug.1 | 4y6g.1 | 4zqc.1 | 5bw6.1 | 5cgq.1 | 6c73.1 | 6d0v.1 | 6duc.1 | 6dz4.1 | 6dzo.1 | 6o1h.1 | 6oso.1 | 6ouy.1 | 6vfd.1 | 6vnt.1 | 6wdu.1 | 6wx3.1 | 6x0c.1 | 6xe3.1 | 6xin.1 | 6xnc.1 | 6xoy.1 | 6xrh.1 | 6xsy.1 | 6xt0.1 | 7jll.1 | 7jmq.1 | 7jmq.2 | 7jqw.1 | 7jtt.1 | 7k0b.1 | 7k5a.1 | 7ka1.1 | 7kbn.1 | 7kh6.1 | 7ki7.1 | 7kmc.1 | 7kq9.1 | 7kqf.1 | 7ku9.1 | 7kwv.1 | 7kxc.1 | 7kyt.1 | 7l03.1 | 7l1h.1 | 7l47.1 | 7l4d.1 | 7l5h.1 | 7lev.1 | 7lgx.1 | 7lkl.1 | 7lpf.1 | 7lt4.1 | 7ltp.1 | 7lut.1 | 7lv5.1 | 7lvx.1 | 7lx1.1 | 7ly8.1 | 7m2l.1 | 7m3s.1 | 7m3s.2 | 7me8.1 | 7mt4.1 | 7mt5.1 | 7mt6.1 | 8b05.1 | 8b06.1 | 8eyp.1 | 8eys.1 | 8ezc.1 | 8rsx.1 | 8rsy.1 | 8rsz.1